Literature DB >> 26260373

Liver: A new copper cut-off value for diagnosis of Wilson disease?

Wolfgang Stremmel1, Uta Merle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26260373     DOI： 10.1038/nrgastro.2015.132

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  EASL Clinical Practice Guidelines: Wilson's disease.

Authors: 
Journal:  J Hepatol       Date:  2012-03       Impact factor: 25.083

2.  Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.

Authors:  Karl Heinz Weiss; Daniel Nils Gotthardt; Daniela Klemm; Uta Merle; Daniela Ferenci-Foerster; Mark Schaefer; Peter Ferenci; Wolfgang Stremmel
Journal:  Gastroenterology       Date:  2010-12-24       Impact factor: 22.682

3.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

4.  Efficacy and safety of oral chelators in treatment of patients with Wilson disease.

Authors:  Karl Heinz Weiss; Florentine Thurik; Daniel Nils Gotthardt; Mark Schäfer; Ulrike Teufel; Franziska Wiegand; Uta Merle; Daniela Ferenci-Foerster; Andreas Maieron; Rudolf Stauber; Heinz Zoller; Hartmut H Schmidt; Ulrike Reuner; Harald Hefter; Jean Marc Trocello; Roderick H J Houwen; Peter Ferenci; Wolfgang Stremmel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-28       Impact factor: 11.382

5.  Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.

Authors:  K Dzieżyc; M Karliński; T Litwin; A Członkowska
Journal:  Eur J Neurol       Date:  2013-12-07       Impact factor: 6.089

6.  Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.

Authors:  U Merle; M Schaefer; P Ferenci; W Stremmel
Journal:  Gut       Date:  2006-05-18       Impact factor: 23.059

7.  Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease.

Authors:  Peter Ferenci; Petra Steindl-Munda; Wolfgang Vogel; Wolfgang Jessner; Michael Gschwantler; Rudolf Stauber; Christian Datz; Franz Hackl; Fritz Wrba; Peter Bauer; Oskar Lorenz
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

8.  Wilson disease: clinical presentation, treatment, and survival.

Authors:  W Stremmel; K W Meyerrose; C Niederau; H Hefter; G Kreuzpaintner; G Strohmeyer
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

9.  Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample.

Authors:  Xu Yang; Xiao-peng Tang; Yong-hong Zhang; Kai-zhong Luo; Yong-fang Jiang; Hong-yu Luo; Jian-hua Lei; Wen-long Wang; Ming-ming Li; Han-chun Chen; Shi-lin Deng; Li-ying Lai; Jun Liang; Min Zhang; Yi Tian; Yun Xu
Journal:  Hepatology       Date:  2015-08-27       Impact factor: 17.425
  9 in total
  2 in total

Review 1.  Disorders of metal metabolism.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-12-18

2.  Biochemical testing for the diagnosis of Wilson's disease: A systematic review.

Authors:  Hafiz Muhammad Salman; Mahwish Amin; Javaria Syed; Zouina Sarfraz; Azza Sarfraz; Muzna Sarfraz; Maria Jose Farfán Bajaña; Miguel Felix; Ivan Cherrez-Ojeda
Journal:  J Clin Lab Anal       Date:  2021-12-23       Impact factor: 2.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.